Intracoronary Injection of CD34+-Cells in Chronic Ischemic Heart Failure: 7 Years Follow-Up of the DanCell Study

Publisher： Karger

E-ISSN： 1421-9751|129|2|69-74

ISSN： 0008-6312

Source： Cardiology, Vol.129, Iss.2, 2014-08, pp. : 69-74

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiorespiratory fitness and risk of heart failure: a population‐based follow‐up study

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 16, Iss. 2, 2014-02 ,pp. : 180-188

John Wiley & Sons Inc

Access to resources Recommend Favorite

Monocyte‐derived and CD34+/KDR+ endothelial progenitor cells in heart failure

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 10, Iss. 7, 2012-07 ,pp. : 1252-1261

John Wiley & Sons Inc

Access to resources Recommend Favorite

Low Risk of Developing Chronic Hepatitis E in Heart Transplant Recipients: A Prospective 2-Year Follow-Up Study

By  

Intervirology, Vol. 59, Iss. 5-6, 2017-04 ,pp. : 254-255

Karger

Access to resources Recommend Favorite

Intracoronary Autologous CD34+ Stem Cell Therapy for Intractable Angina

By  

Cardiology, Vol. 117, Iss. 2, 2010-10 ,pp. : 140-147

Karger

Access to resources Recommend Favorite

Ischemic bowel disease and risk of stroke: a one‐year follow‐up study

By  

INTERNATIONAL JOURNAL OF STROKE, Vol. 9, Iss. 8, 2014-12 ,pp. : 1083-1089

John Wiley & Sons Inc

Access to resources Recommend Favorite